These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Biodegradable-polymer drug-eluting stents: back to the future? Cassese S; Xhepa E; Kastrati A Heart; 2017 Jan; 103(2):91-92. PubMed ID: 27628493 [No Abstract] [Full Text] [Related]
9. Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome. Jaguszewski M; Dörig M; Frangieh AH; Ghadri JR; Cammann VL; Diekmann J; Napp LC; D'Ascenzo F; Imori Y; Obeid S; Maier W; Lüscher TF; Templin C Catheter Cardiovasc Interv; 2016 Nov; 88(6):E173-E182. PubMed ID: 27377554 [TBL] [Abstract][Full Text] [Related]
10. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial. Orvin K; Carrie D; Richardt G; Desmet W; Assali A; Werner G; Ikari Y; Fujii K; Goicolea J; Dangoisse V; Manari A; Saito S; Wijns W; Kornowski R Catheter Cardiovasc Interv; 2016 May; 87(6):1092-100. PubMed ID: 26268482 [TBL] [Abstract][Full Text] [Related]
11. Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Shah R Ann Intern Med; 2016 Dec; 165(11):828-829. PubMed ID: 27919089 [No Abstract] [Full Text] [Related]
12. Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents. Zhang XL; Xu B Ann Intern Med; 2016 Dec; 165(11):829. PubMed ID: 27919088 [No Abstract] [Full Text] [Related]
13. Vascular response to bioresorbable polymer sirolimus-eluting stent vs. permanent polymer everolimus-eluting stent at 9-month follow-up: an optical coherence tomography sub-study from the CENTURY II trial. Kuramitsu S; Kazuno Y; Sonoda S; Domei T; Jinnouchi H; Yamaji K; Soga Y; Shirai S; Ando K; Saito S Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):34-40. PubMed ID: 26333375 [TBL] [Abstract][Full Text] [Related]
14. Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. Kufner S; Byrne RA; Valeskini M; Schulz S; Ibrahim T; Hoppmann P; Schneider S; Laugwitz KL; Schunkert H; Kastrati A; EuroIntervention; 2016 Mar; 11(12):1372-9. PubMed ID: 25405657 [TBL] [Abstract][Full Text] [Related]
15. Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations. Costopoulos C; Latib A; Naganuma T; Sticchi A; Ferrarello S; Regazzoli D; Chieffo A; Figini F; Carlino M; Montorfano M; Naim C; Kawaguchi M; Gerasimou A; Giannini F; Godino C; Colombo A Catheter Cardiovasc Interv; 2014 May; 83(6):889-95. PubMed ID: 23804318 [TBL] [Abstract][Full Text] [Related]
16. In-vitro mechanical behavior and in-vivo healing response of a new generation biodegradable polymer-coated thin-strut sirolimus-eluting stents. Gąsior P; Pyka Ł; Hawranek M; Garbacz M; Chagnon M; Beaudry D; Fluder J; Gąsior M; Wojakowski W; Lekston A Kardiol Pol; 2022; 80(1):72-75. PubMed ID: 34775590 [No Abstract] [Full Text] [Related]